ArticleESMO gastrointestinal oncology2026

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

H Vandeputte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.